Research sheds new light on impact of diabetes on the brain

April 17, 2014 by Amy Pullan, University of Sheffield
Research sheds new light on impact of diabetes on the brain
Detailed anatomical magnetic resonance image of the brain.

Researchers from the University of Sheffield and Sheffield Teaching Hospitals NHS Foundation Trust have discovered diabetic nerve damage causes more harm in the brain than previously thought, shedding new light on the disease.

The new findings published in the Diabetes Care journal reveal the extent of damage patients suffering with the disease can endure in areas of the brain called 'grey matter' – a key component of the central nervous system which is involved in touch and pain sensory perception.

During the study, which involved patients with Type 1 and Type 2 diabetes, researchers used recent advances in ground breaking brain imaging and analyses methods to take detailed nerve assessments of the brain using (MRI) techniques.

This revealed that the volume of certain brain regions in people with was significantly lower compared to those without the disease. Previous studies have shown that the impact of the disease on the brain is limited and isolated to outside areas of the brain considered to be peripheral to core functions in the body.

The breakthrough could pave the way for better assessment and monitoring of the disease, which affects around a third of people with diabetes. This, in turn, could lead to better treatments for sufferers in the future.

Diabetes patient Tracey Smythe, 45, of Parson Cross, Sheffield, admits she had little understanding of diabetic neuropathy – which affects up to a third of patients suffering with Type 1 and Type 2 diabetes – when she was first diagnosed with the illness five years ago.

Now she finds "living with the disease hard" and crippling pains from the illness stop her from doing the simplest things – including walking her two dogs, going to the supermarket alone and wearing clothes with zips and buttons.

Research sheds new light on impact of diabetes on the brain
Brain scan.

"It affects all aspects of my life. I get shooting pains that take me off my feet. One time the pain lasted four and a half hours. I couldn't get up the stairs without using my arms to pull me up. I was in on my own, and I felt frightened and vulnerable. "

She added: "Even walking my two dogs is impossible as the pain increases when I'm walking. All the time I'm taking risk assessments on what I can and can't do. If I'm making a cup of tea I need to ask myself if I'm going to be alright.

"My hands get swollen and numb and I'm constantly getting pins and needles. My husband has to be there when I'm cooking, and I can't even bake a cake without him helping do the mix. Even the weather affects me, and if it gets too hot or cold I feel worse.

"Imagine you've gone out on a good night and worn the tightest pair of shoes, and the next day your feet are killing you. That's what it's like constantly living with diabetic nerve damage. I just wish there was more doctors could do to help people like me, which is why better understanding of the disease through research is vital."

The pioneering research, which will benefit patients like Tracey, was conducted by Dr Dinesh Selvarajah, a Senior Lecturer and Honorary Consultant in Diabetes at the Royal Hallamshire Hospital and a team from Sheffield Teaching Hospitals NHS Foundation Trust and University of Sheffield led by Professor Solomon Tesfaye and Professor Iain Wilkinson.

The research was funded by JDRF, the leading global funder of Type 1 diabetes research.

Dr Dinesh Selvarajah, of the Royal Hallamshire Hospital, said: "Diabetic nerve damage has a massive impact on the quality of people's lives, physically, mentally and socially.

"With the number of people suffering from diabetes around the world soaring, these are significant findings. Our study reveals for the first time how extensively involved diabetic neuropathy is in the brain, causing shrinking and a reduction in the main part of the brain associated with sensation. This is a new insight which will go a long way towards helping us better understand, treat and prevent a disease which we thought to be fairly innocuous in terms of effects on the brain.

"The next steps will be for us to investigate at what stage this occurs, what the consequences of this are and whether it can be prevented as it could be impacting on patient's behaviour and psychology."

Iain Wilkinson, an MR Physics Professor within Academic Radiology at the University of Sheffield and an Honorary Consultant Clinical Scientist for Sheffield Teaching Hospitals NHS Foundation Trust, said: "To see leading-edge MRI technology pinpoint changes that might play an influential factor in the quality of so many lives highlights the need for clinical research like this. It's such an important part of our Teaching Hospital and University.

"MRI is such a useful neuroimaging tool in both medicine and patient-based medical research. The technique that we have been using is often termed 'volumetry' – recent scanner improvements enable the collection of high quality, high resolution, 3D datasets of the brain in an acceptable time, which, when coupled with the latest image processing systems, enable us to look at, or 'segment', different parts of the brain in patients who do or do not have diabetic neuropathy. The overall technique indicates where the differences that we are observing are occurring."

The grey matter region identified is a major component of the central nervous system, consisting of brain cells (or neurons) which process information from sensory organs in order to decide and execute functions. Loss of nerve cells in the grey matter, more properly known as cerebral atrophy, is highly undesirable as the functions of that area of the can become impaired.

Explore further: Discovery points to a way to reverse suffering of diabetic nerve pain

Related Stories

Discovery points to a way to reverse suffering of diabetic nerve pain

August 8, 2013
For people with diabetes who suffer from peripheral neuropathy, a gentle touch can be agony. A warm shower can be torture. New research at the University of Virginia School of Medicine, however, has shed light on the causes ...

Drug offers new pain management therapy for diabetics

October 30, 2012
A study from the University of Calgary's Hotchkiss Brain Institute shows there is evidence to support a new drug therapy called nabilone to treat diabetic neuropathy, or nerve pain. Researchers enrolled 60 patients with diabetic ...

Older age at onset of Type 1 diabetes associated with lower brain connectivity

March 14, 2014
Children and adolescents older than age 8 at the onset of type 1 diabetes had weaker brain connectivity when tested later in life relative to those who had earlier ages of diagnosis, University of Pittsburgh Schools of the ...

Researchers explore impact of gut disease on young people's identity

January 15, 2014
(Medical Xpress)—A new study looking at the impact inflammatory bowel disease may have on young people's relationships, employment potential and identity is being launched in Sheffield.

Autoimmune drug may help prevent kidney disease caused by diabetes

March 27, 2014
A drug currently used to treat autoimmune disease may also help prevent the kidney-damaging effects of diabetes, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN). ...

Scientists discover new biological marker for Parkinson's disease

September 20, 2013
Researchers in Nottingham have discovered a new biological indicator which could potentially help to track the progress of Parkinson's disease using powerful MRI scanners.

Recommended for you

Diabetes gene found that causes low and high blood sugar levels in the same family

January 15, 2018
A study of families with rare blood sugar conditions has revealed a new gene thought to be critical in the regulation of insulin, the key hormone in diabetes.

Discovery could lead to new therapies for diabetics

January 12, 2018
New research by MDI Biological Laboratory scientist Sandra Rieger, Ph.D., and her team has demonstrated that an enzyme she had previously identified as playing a role in peripheral neuropathy induced by cancer chemotherapy ...

Enzyme shown to regulate inflammation and metabolism in fat tissue

January 11, 2018
The human body has two primary kinds of fat—white fat, which stores excess calories and is associated with obesity, and brown fat, which burns calories in order to produce heat and has garnered interest as a potential means ...

Big strides made in diabetes care

January 5, 2018
(HealthDay)—This past year was a busy, productive one for diabetes research and care.

Gene therapy restores normal blood glucose levels in mice with type 1 diabetes

January 4, 2018
Type 1 diabetes is a chronic disease in which the immune system attacks and destroys insulin-producing beta cells in the pancreas, resulting in high blood levels of glucose. A study published January 4th in Cell Stem Cell ...

Goodbye, needles? Patch might be the future for blood-sugar tracking

January 4, 2018
(HealthDay)—Developers of a new patch hope to eliminate a big barrier in type 2 diabetes treatment—painful finger-sticks and injections. The new patch—which actually uses an array of tiny needles that researchers promise ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

not rated yet Apr 17, 2014

Do any neuropathy sufferers use prescription strength topical gels to relief their pain? If so, could you please tell me more about them. I'm curious...

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.